多囊卵巢综合征不孕妇女助孕时机与助孕方式选择

摘要/Abstract

摘要：

多囊卵巢综合征(polycystic ovary syndrome, PCOS)是最常见的导致排卵障碍性不孕症的原因。对于PCOS患者，助孕方法有很多种，主要包括：改变生活方式、胰岛素增敏剂、选择性雌激素受体拮抗剂、芳香化酶抑制剂、促性腺激素、腹腔镜卵巢打孔以及辅助生殖技术等。这些方法的作用机制、适用范围各不相同，各有优缺点。该文就多囊卵巢综合征不孕妇女助孕时机与助孕方式选择做一阐述。

关键词: 多囊卵巢综合征, 不孕症, 促排卵, 辅助生殖技术

Abstract:

Abstract：Polycystic ovary syndrome (PCOS) is the most common cause of anovulatory infertility. There are multiple ways to induce ovulation in PCOS patients, which will eventually provide a successful live birth. Each of these treatments varies in aggressiveness and effectiveness. Ranging from lifestyle modifications, through insulin-sensitizing agents, selective estrogen receptor modulators, aromatase inhibitors, gonadotr opins, to laparoscopic ovarian drilling and assisted reproductive techniques, each method achieves ovulation induction through different mechanisms of action. This paper provides a description and specific characteristics of the different methods used for ovulation induction which can help to design a personalized approach to each PCOS patient, and a general stepwise approach to ovulation induction in these patients.

Key words: polycystic ovary syndrome, infertility, ovulation induction, assisted reproductive techniques

中图分类号:

R711.75

艾继辉，赵义清，朱桂金. 多囊卵巢综合征不孕妇女助孕时机与助孕方式选择[J]. 中国实用妇科与产科杂志.

参考文献

[1］ Hart R, Hickey M, Franks S. Definitions, prevalence and symptoms of polycystic ovaries and polycystic ovary syndrome［J］. Best Pract Res Clin Obstet Gynaecol, 2004,18(5):671-683.

[2］ Thessaloniki ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group.Consensus on infertility treatment related to polycystic ovary syndrome［J］. Hum Reprod, 2008,23(3):462-477.

[3］ Pasquali R, Gambineri A. Polycystic ovary syndrome: a multifaceted disease from adolescence to adult age［J］. Ann N Y Acad Sci, 2006,1092:158-174.

[4］ Shannon M, Wang Y. Polycystic ovary syndrome: a common but often unrecognized condition［J］. J Midwifery Womens Health, 2012,57(3):221-230.

[5］ Moran LJ, Noakes M, Clifton PM, et al. Short-term meal replacements followed by dietary macronutrient restriction enhance weight loss in polycystic ovary syndrome［J］. Am J Clin Nutr, 2006,84(1):77-87.

[6］ Moran LJ, Hutchison SK, Norman RJ, et al. Lifestyle changes in women with polycystic ovary syndrome［J］. Cochrane Database Syst Rev, 2011,(2):CD007506.

[7］ Teede HJ, Misso ML, Deeks AA, et al. Assessment and management of polycystic ovary syndrome: summary of an evidence-based guideline［J］. Med J Aust, 2011,195(6):S65-112.

[8］ Tang T, Lord JM, Norman RJ, et al. Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility［J］. Cochrane Database Syst Rev, 2012,5:CD003053.

[9］ Morin-Papunen L, Rantala AS, Unkila-Kallio L, et al. Metformin improves pregnancy and live-birth rates in women with polycystic ovary syndrome (PCOS): a multicenter, double-blind, placebo-controlled randomized trial［J］. J Clin Endocrinol Metab, 2012,97(5):1492-500.

[10］ Palomba S, Falbo A, Zullo F. Management strategies for ovulation induction in women with polycystic ovary syndrome and known clomifene citrate resistance［J］. Curr Opin Obstet Gynecol, 2009,21(6):465-473.

[11］ Diamond MP, Kruger M, Santoro N, et al. Endometrial shedding effect on conception and live birth in women with polycystic ovary syndrome［J］. Obstet Gynecol, 2012,119(5):902-908.

[12］ Messinis IE. Ovulation induction: a mini review［J］. Hum Reprod, 2005,20(10):2688-2697.

[13］ Yildizhan R, Adali E, Kolusari A, et al. Ovarian stimulation in obese and non-obese polycystic ovary syndrome using a low-dose step-up regimen with two different starting doses of recombinant follicle-stimulating hormone［J］. J Int Med Res, 2008,36(6):1197-1204.

[14］ Hart R. PCOS and infertility［J］. Panminerva Med, 2008,50(4):305-314.

[15］罗丽兰. 不孕与不育［M］. 2版. 北京:人民卫生出版社,2009：123.

[16］ Homburg R, Berkowitz D, Levy T, et al. In vitro fertilization and embryo transfer for the treatment of infertility associated with polycystic ovary syndrome［J］. Fertil Steril, 1993,60(5):858-863.

[17］ Urman B, Fluker MR, Yuen BH, et al. The outcome of in vitro fertilization and embryo transfer in women with polycystic ovary syndrome failing to conceive after ovulation induction with exogenous gonadotropins［J］. Fertil Steril, 1992,57(6):1269-1273.

[18］ Wang XX, Luan CX, Zhang W, et al. Pregnancy outcomes of in vitro fertilization and embryo transfer in infertile women with polycystic ovarian syndrome［J］.Zhonghua Fu Chan Ke Za Zhi, 2012,47(10):730-733.

[19］ Trounson A, Wood C, Kausche A. In vitro maturation and the fertilization and developmental competence of oocytes recovered from untreated polycystic ovarian patients［J］. Fertil Steril, 1994,62(2):353-362.

[20］ Barnes FL, Crombie A, Gardner DK, et al. Blastocyst development and birth after in-vitro maturation of human primary oocytes, intracytoplasmic sperm injection and assisted hatching［J］. Hum Reprod, 1995,10(12):3243-3247.

[21］ Chian RC, Buckett WM, Tan SL. In-vitro maturation of human oocytes［J］. Reprod Biomed Online, 2004,8(2):148-166.

[22］ Tan SL, Child TJ. In-vitro maturation of oocytes from unstimulated polycystic ovaries［J］. Reprod Biomed Online, 2002,4 Suppl 1:18-23.

[23］ Child TJ, Phillips SJ, Abdul-Jalil AK, et al. A comparison of in vitro maturation and in vitro fertilization for women with polycystic ovaries［J］. Obstet Gynecol, 2002,100(4):665-670.

[1]	黄晨阳, 孙海翔. 妇科恶性肿瘤患者促排卵及胚胎移植方案的选择[J]. 中国实用妇科与产科杂志, 2022, 38(6): 614-618.
[2]	邓姗, 田秦杰. 子宫内膜息肉与生育[J]. 中国实用妇科与产科杂志, 2022, 38(3): 273-276.
[3]	黄珈. 黄体期促排卵的利弊分析[J]. 中国实用妇科与产科杂志, 2021, 37(4): 435-440.
[4]	刘芬婷, 李蓉. 女性生殖道感染对辅助生殖技术妊娠结局的影响#br#[J]. 中国实用妇科与产科杂志, 2021, 37(10): 1007-1012.
[5]	孙莹璞，卜志勤. 重视不孕症的子宫因素及其处理[J]. 中国实用妇科与产科杂志, 2020, 36(6): 481-482.
[6]	熊玉晶，徐艳文. 不孕症合并慢性子宫内膜炎的诊治[J]. 中国实用妇科与产科杂志, 2020, 36(6): 488-491.
[7]	古芳. 不孕症合并子宫内膜息肉的临床处理及预后[J]. 中国实用妇科与产科杂志, 2020, 36(6): 491-495.
[8]	宋天然，孙海翔. 子宫内膜损伤致不孕症的临床处理[J]. 中国实用妇科与产科杂志, 2020, 36(6): 500-504.
[9]	石一复，李娟清. 不孕症合并子宫肌瘤的处理原则[J]. 中国实用妇科与产科杂志, 2020, 36(6): 512-516.
[10]	冷金花，史精华. 子宫腺肌病合并不孕治疗策略[J]. 中国实用妇科与产科杂志, 2020, 36(6): 516-519.
[11]	邓姗，田秦杰. 子宫发育异常合并不孕症的诊治策略[J]. 中国实用妇科与产科杂志, 2020, 36(6): 519-523.
[12]	乔杰，齐新宇，徐雅兰，庞艳莉. 关注影响女性健康的重要生殖内分泌疾病多囊卵巢综合征[J]. 中国实用妇科与产科杂志, 2020, 36(1): 1-9.
[13]	林小娜，张松英. 子宫腺肌病对生育的影响和治疗选择[J]. 中国实用妇科与产科杂志, 2019, 35(5): 510-512.
[14]	李昕. 多囊卵巢综合征心理问题及管理[J]. 中国实用妇科与产科杂志, 2019, 35(3): 295-297.
[15]	李琳，杨冬梓. 青春期多囊卵巢综合征筛查与管理[J]. 中国实用妇科与产科杂志, 2019, 35(3): 291-295.